EVOLVE 4 GROUP LIMITED

Company number 12719900 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

EVOLVE 4 GROUP LIMITED - Analysis Report

Company Number: 12719900

Analysis Date: 2025-07-20 18:37 UTC

Financial Health Assessment for EVOLVE 4 GROUP LIMITED


1. Financial Health Score: D

Explanation:
The company exhibits significant financial distress characterized by persistent operating losses, negative net assets, and a working capital deficit. Despite being an active private limited holding company with stable ownership, its balance sheet and liquidity indicators suggest vulnerability. The going concern is under material uncertainty, indicating that without corrective measures, the company faces a risk of insolvency.


2. Key Vital Signs

Vital Sign 2023 Value (£) Interpretation
Turnover 0 No revenue generation, indicating no operating cash inflows from trading activities.
Operating Loss (53,677) Continuous operating losses signaling unprofitable operations.
Fixed Assets (Intangibles + Tangibles) 326,867 Significant fixed asset base primarily intangible, which may be illiquid or slow to convert.
Debtors (Receivables) 185,217 Outstanding receivables, but without turnover, potentially related-party or non-trading.
Current Liabilities 417,705 High short-term obligations exceeding current assets, indicating liquidity strain.
Net Current Assets (Working Capital) (232,488) Negative working capital, a symptom of cash flow distress and inability to cover short-term debts.
Long-term Liabilities 247,805 Substantial non-current liabilities worsening the solvency position.
Net Assets (Equity) (153,426) Negative equity reflecting accumulated losses and financial strain.
Share Capital 10,000 Modest equity base insufficient to absorb losses.
Ownership Control Hilton Foods Ltd (75-100%) Majority owned by a larger entity which may provide support or exert influence.

3. Diagnosis: Financial Condition Overview

EVOLVE 4 GROUP LIMITED is currently in a state akin to a patient with chronic illness. The company shows symptoms of financial distress:

  • Persistent Operating Losses: The company recorded losses of approximately £53.7k in 2023, continuing a trend from the previous year, without any turnover. This indicates an inability to generate operating income, much like a patient with a failing organ function.

  • Negative Working Capital: The working capital is deeply negative (£-232k), meaning the firm lacks the "healthy cash flow" needed to cover its short-term liabilities. This is comparable to a patient with deficient blood flow to vital organs—liquidity problems can cause operational breakdown.

  • Negative Net Assets: Shareholders’ funds are negative by over £153k, showing that liabilities exceed assets. This is a key red flag of insolvency risk, akin to a patient whose vital signs have dropped below critical thresholds.

  • Material Uncertainty on Going Concern: The auditors have highlighted a material uncertainty relating to the company’s ability to continue as a going concern. This is the medical equivalent of a critical diagnosis indicating prognosis depends heavily on intervention.

  • Holding Company Role: The company acts as a holding entity with no trading turnover, which can explain some financial inactivity but also raises concerns about dependency on parent or group companies for funding and sustainability.

  • Recent Director Changes: The company underwent a director reshuffle in August 2023, possibly indicating strategic repositioning or management response to financial stress.


4. Recommendations: Path to Financial Wellness

To improve EVOLVE 4 GROUP LIMITED’s financial health, consider the following actions:

  1. Revenue Generation or Asset Monetization:
    Develop or activate operational entities under the holding company to generate turnover. Alternatively, monetize or reassess intangible fixed assets to improve liquidity.

  2. Cost Control and Expense Reduction:
    Review administrative expenses and overheads to reduce the operating loss burden. Even as a holding company, overheads should be minimized to preserve cash.

  3. Debt Restructuring:
    Negotiate with creditors to extend payment terms, reduce liabilities, or convert debt into equity where possible. This will ease the liquidity crunch and improve working capital.

  4. Equity Injection or Financial Support:
    Engage the parent company (Hilton Foods Limited) or external investors for fresh equity capital to restore positive net assets and strengthen the balance sheet.

  5. Enhanced Cash Flow Management:
    Implement tighter cash flow forecasting and controls, and align payment terms with counterparties to ensure smoother liquidity management.

  6. Regular Monitoring and Reporting:
    Institute monthly financial health check-ups focusing on liquidity, solvency, and operational metrics to catch symptoms of distress early.


Medical Analogy Summary:

EVOLVE 4 GROUP LIMITED is currently showing "symptoms of financial distress," such as "negative working capital" and "operating losses," which are red flags indicating a "weak cardiovascular system" of the business. The "going concern" is under threat, akin to a patient in critical condition. Intervention through restructuring, capital infusion, and operational activation is essential to steer the company back to a state of "financial wellness."


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.